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Background
The development of immune monitoring models to
determine HIV-1 vaccine efficacy is a major challenge.
HIV-1-specific CD8 T cells likely play a critical role in
individuals achieving spontaneous viral control (HIV-1
controllers) and will be important in immune interven-
tions. However, no single CD8 T cell function is
uniquely associated with controller status.
Methods
Here we describe the building of immune monitoring
models based on inter- and intra-donor analysis of HIV-1-
specific CD8 T cell proliferation and cytokine secretion
assessed at different time points after antigen stimulation.
The discovery data set used to build a palette of immune
monitoring models of HIV-1-specific CD8 T cell functions
was generated on 26 controllers, 15 progressors and 23
ART-treated subjects. An independent cohort of 10 con-
trollers and 10 progressors was investigated to validate our
results. We used Area Under the Receiving Operating
Characteristic curves (AUC) to assess the ability of indivi-
dual variables to differentiate between controllers and
non-controllers.
Results
Our analyses identified links between HIV-1-specific
CD8 T functions, HLA-I alleles, and disease stage. The
best accuracy (AUC) values were observed for prolifera-
tion. Early (6h) IL-2 secretion and slopes of TNF-a,I L - 2
and IFN-g production also contributed to the models
whereas gender and age had no discriminatory value. A
model incorporating five HIV-1-specific CD8 T cell func-
tions achieved 90% accuracy in the discovery cohort on
which it was trained, and was able to accurately discrimi-
nate controllers from non-controllers in the validation
cohort.
Conclusion
Our multidimensional modeling approach shows that inte-
gration of different dimensions of data leverages indepen-
dent associations and discriminates much better than any
one measure. This modeling approach is amenable to
incremental incorporation of new knowledge to build
evolving flexible tools that are usable in translational clini-
cal research and thus, has important applications in pre-
dictive model development and immune monitoring of
HIV-1 vaccine trials.
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